source
- Mirum reports Phase 3 success for its acquired hepatitis D therapyMirum Pharmaceuticals announced that its recently acquired chronic hepatitis delta drug met its primary endpoint in a Phase 3 trial. The study tested a once-weekly 300 mg injection, and more than…
- White House seeks data on U.S. manufacturing of 86 essential medicinesThe White House Office of Management and Budget has launched a review of domestic production for a list of 86 medicines deemed essential. The request asks manufacturers to provide information on w…